Immunotherapy of anogenital warts with measles, mumps, and rubella vaccine.

Abstract

Anogenital warts, caused by the human papillomavirus, are a cause of significant discomfort and psychological concern for the patients. Despite the availability of multiple treatment options, they are a challenge to manage and may be quite refractory. An easy-to-use therapeutic method with low adverse event profile and low-recurrence rate, therefore, remains highly desirable. In this brief paper, an attempt is made to review the intralesional immunotherapy of anogenital warts with measles, mumps, and rubella vaccine.

• Authors: Naveen Kumar Kansal
• Journal: Dermatologic therapy (Dermatol Ther) Vol. 33 Issue 6 Pg. e13987 (11 2020) ISSN: 1529-8019 [Electronic] United States
• PMID: 32638481 (Publication Type: Journal Article)
• Copyright: © 2020 Wiley Periodicals LLC.

Chemical References

• Measles-Mumps-Rubella Vaccine

Topics

• Humans
• Immunotherapy
• Infant
• Injections, Intralesional
• Measles
• Measles-Mumps-Rubella Vaccine
• Mumps
• Warts